FI821821A0 - IMMUNOKEMISK BESTAEMNING AV SUR PROSTATAFOSFATAS - Google Patents

IMMUNOKEMISK BESTAEMNING AV SUR PROSTATAFOSFATAS

Info

Publication number
FI821821A0
FI821821A0 FI821821A FI821821A FI821821A0 FI 821821 A0 FI821821 A0 FI 821821A0 FI 821821 A FI821821 A FI 821821A FI 821821 A FI821821 A FI 821821A FI 821821 A0 FI821821 A0 FI 821821A0
Authority
FI
Finland
Prior art keywords
antibody
isoenzyme
precipitate
sample
immunocomplexes
Prior art date
Application number
FI821821A
Other languages
Finnish (fi)
Other versions
FI821821A (en
Inventor
Hans Jacob Hager
Magdalena Usategui Gomez
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI821821A0 publication Critical patent/FI821821A0/en
Publication of FI821821A publication Critical patent/FI821821A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/548Carbohydrates, e.g. dextran

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Amplifiers (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1. Claims for the Contracting States BE, CH, DE, FR, GB, IT, LI, NL, SE A process for determining the amount of prostatic acid phosphatase isoenzyme in a biological fluid sample, characterized by a) incubating the sample with (i) a soluble first antibody which selectively binds immunologically to the isoenzyme in the sample without inhibiting the enzymatic activity of this isoenzyme, and (ii) an insolubilized antibody formed by coupling this second antibody to amylose whereby the second antibody selectively binds immunologically to the first antibody without inhibiting the enzymatic activity of the isoenzyme, to obtain a precipitate of a mixture of immunocomplexes which contain isoenzyme-first antibody-second antibody and first antibody-second antibody, and b) isolating the precipitate containing the immunocomplexes and c) measuring the isoenzyme activity in the precipitate. 1. Claims for the Contracting State AT A process for determining the amount of prostatic acid phosphatase isoenzyme in a biological fluid sample, characterized by a) incubating the sample with (i) a soluble first antibody which selectively binds immunologically to the isoenzyme in the sample without inhibiting the enzymatic activity of this isoenzyme, and (ii) an insolubilized antibody formed by coupling this second antibody to amylose, whereby the second antibody selectively binds immunologically to the first antibody without inhibiting the enzymatic activity of the isoenzyme, to obtain a precipitate of a mixture of immunocomplexes which contain isoenzyme-first antibody-second antibody and first antibody-second antibody, and b) isolating the precipitate containing the immunocomplexes and c) measuring the isoenzyme activity in the precipitate.
FI821821A 1981-06-22 1982-05-21 IMMUNOKEMISK BESTAEMNING AV SUR PROSTATAFOSFATAS FI821821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27622381A 1981-06-22 1981-06-22

Publications (2)

Publication Number Publication Date
FI821821A0 true FI821821A0 (en) 1982-05-21
FI821821A FI821821A (en) 1982-12-23

Family

ID=23055717

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821821A FI821821A (en) 1981-06-22 1982-05-21 IMMUNOKEMISK BESTAEMNING AV SUR PROSTATAFOSFATAS

Country Status (10)

Country Link
EP (1) EP0068291B1 (en)
JP (1) JPS585661A (en)
AT (1) ATE16407T1 (en)
AU (1) AU539531B2 (en)
CA (1) CA1185525A (en)
DE (1) DE3267265D1 (en)
DK (1) DK261282A (en)
ES (1) ES513286A0 (en)
FI (1) FI821821A (en)
NO (1) NO822067L (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US6942862B2 (en) 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
CN103808712B (en) * 2012-11-05 2017-12-19 深圳迈瑞生物医疗电子股份有限公司 A kind of liquid reagent box and detection method for acid phosphatase detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048298A (en) * 1975-02-25 1977-09-13 Rohm And Haas Company Solid phase double-antibody radioimmunoassay procedure
US4224406A (en) * 1978-02-27 1980-09-23 Hoffmann-La Roche Inc. Immunochemical LDH1 assay
US4260678A (en) * 1979-02-23 1981-04-07 Corning Glass Works Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
DE2952478A1 (en) * 1979-12-27 1981-07-30 Merck Patent Gmbh, 6100 Darmstadt METHOD AND MEANS FOR THE IMMUNOLOGICAL DETERMINATION OF ENZYMES

Also Published As

Publication number Publication date
ES8307378A1 (en) 1983-07-01
DE3267265D1 (en) 1985-12-12
CA1185525A (en) 1985-04-16
AU8505182A (en) 1983-01-06
ATE16407T1 (en) 1985-11-15
EP0068291B1 (en) 1985-11-06
DK261282A (en) 1982-12-23
EP0068291A1 (en) 1983-01-05
NO822067L (en) 1982-12-23
AU539531B2 (en) 1984-10-04
FI821821A (en) 1982-12-23
ES513286A0 (en) 1983-07-01
JPS585661A (en) 1983-01-13

Similar Documents

Publication Publication Date Title
FR2602592B1 (en) USE OF THE ENZYMATIC XANTHINE-OXYDASE SYSTEM IN IMMUNOALYSIS, CORRESPONDING ASSAY PROCESSES AND REAGENT PACKAGES NECESSARY FOR THE IMPLEMENTATION OF THESE PROCESSES.
DK0649535T3 (en) Method to improve measurement precision in optical biosensor assays with detection of spatially attenuated waves
ZA877719B (en) Immunoassay based on two enzyme inhibition system
JPS5592693A (en) Determination of ligand
FR2413400A1 (en) INSOLUBILIZED AND STABILIZED BIOCHEMICALS AND THEIR APPLICATION AS IMMUNOCHEMICAL REAGENTS
ES2063821T3 (en) REAGENT COMPOSITION INCLUDING AN ENZYME GIVER.
DE69322959T2 (en) SENSOR FOR OPTICAL INSPECTION
SE8200897L (en) Immunochemical enzyme determination
AU559469B2 (en) Single incubation immunochemical assay
ATE37199T1 (en) ENZYMATIC DETERMINATION OF UREA.
FI821821A0 (en) IMMUNOKEMISK BESTAEMNING AV SUR PROSTATAFOSFATAS
DK392489A (en) SIGNAL REINFORCEMENT IN TEST FOR AN ENZYM
DE3473475D1 (en) Process for determining substrate or enzymatic activity
ES537835A0 (en) PROCEDURE FOR THE SPECIFIC DETERMINATION OF EXISTING PANCREATIC A-AMYLASE NEXT TO SALIVA A-AMYLASE
Choe et al. Immunoenzyme assay for human prostatic acid phosphatase
DE3585398D1 (en) NON-SPECIFIC REACTION INHIBITOR IN AN IMMUNOLOGICAL TEST USING A MONOCLONAL ANTIBODY.
DK16384A (en) METHOD FOR DETERMINING DEOXYTHYMIDINE DINASE (DTK) ISOENZYM ACTIVITY
ATE78599T1 (en) PROCEDURE FOR DETERMINING AND COUNTING PARTICULATE ANTIGENS IN A LIQUID SAMPLE, PARTICULARLY OF CLOSTRIDIUM BUTYRIC SporeS IN MILK.
ES481516A1 (en) Test means and assay for deter- mining the urea content of fluids
SE7906066L (en) PROCEDURE FOR DETERMINING CREATINKINASES IN SAMPLES CONTAINING ATP
JPS5567653A (en) Measuring method of methotrexate concentration in body fluids and combination of measuring reagent
ES436168A1 (en) An assay method for colorimetrically determining the amount of an enzyme present in a female biological medium. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F HOFFMANN-LA ROCHE & CO